Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gastroenterology|June 1, 1993
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath testY F Ghoos, B D Maes, B J Geypens, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solidsB D Maes, Y F Ghoos, B J Geypens, et al.European Journal of Gastroenterology & Hepatology|November 27, 1998
Hypertrophic lymphocytic gastritis with a gastric carcinomaK M Vandenborre, G L Ghillebert, L J Rutgeerts, et al.Gastroenterology|December 31, 1998
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisF J Baert, G R D'Haens, M Peeters, et al.Digestive Diseases and Sciences|March 1, 1996
Gastric emptying and Helicobacter pylori infection in duodenal ulcer diseaseF Perri, Y F Ghoos, B D Maes, et al.The Journal of Pathology|January 1, 1994
Whipple's disease: a histological, immunocytochemical, and electron microscopic study of the small intestinal epitheliumN L Ectors, K J Geboes, R M De Vos, et al.Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.Alimentary Pharmacology & Therapeutics|June 2, 2017
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitisG R D'Haens, W J Sandborn, G Zou, et al.Pageof 3